Ad is loading...
BNTX
Price
$99.72
Change
-$3.84 (-3.71%)
Updated
Nov 15 closing price
113 days until earnings call
SMMT
Price
$18.31
Change
-$1.14 (-5.86%)
Updated
Nov 15 closing price
116 days until earnings call
Ad is loading...

BNTX vs SMMT

Header iconBNTX vs SMMT Comparison
Open Charts BNTX vs SMMTBanner chart's image
BioNTech SE American Depositary Share
Price$99.72
Change-$3.84 (-3.71%)
Volume$3.38M
CapitalizationN/A
Summit Therapeutics
Price$18.31
Change-$1.14 (-5.86%)
Volume$2.15M
CapitalizationN/A
BNTX vs SMMT Comparison Chart
Loading...
BNTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SMMT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BNTX vs. SMMT commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNTX is a Sell and SMMT is a StrongSell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (BNTX: $99.72 vs. SMMT: $18.31)
Brand notoriety: BNTX and SMMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BNTX: 291% vs. SMMT: 43%
Market capitalization -- BNTX: $23.91B vs. SMMT: $13.5B
BNTX [@Biotechnology] is valued at $23.91B. SMMT’s [@Biotechnology] market capitalization is $13.5B. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BNTX’s FA Score shows that 2 FA rating(s) are green whileSMMT’s FA Score has 2 green FA rating(s).

  • BNTX’s FA Score: 2 green, 3 red.
  • SMMT’s FA Score: 2 green, 3 red.
According to our system of comparison, SMMT is a better buy in the long-term than BNTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BNTX’s TA Score shows that 3 TA indicator(s) are bullish while SMMT’s TA Score has 2 bullish TA indicator(s).

  • BNTX’s TA Score: 3 bullish, 5 bearish.
  • SMMT’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, BNTX is a better buy in the short-term than SMMT.

Price Growth

BNTX (@Biotechnology) experienced а -9.87% price change this week, while SMMT (@Biotechnology) price change was -14.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

BNTX is expected to report earnings on Mar 10, 2025.

SMMT is expected to report earnings on Mar 13, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BNTX($23.9B) has a higher market cap than SMMT($13.5B). BNTX has higher P/E ratio than SMMT: BNTX (161.76) vs SMMT (26.36). SMMT YTD gains are higher at: 601.533 vs. BNTX (-5.514). SMMT has higher annual earnings (EBITDA): -183.16M vs. BNTX (-315.6M). BNTX has more cash in the bank: 17.3B vs. SMMT (487M). SMMT has less debt than BNTX: SMMT (32.5M) vs BNTX (255M). BNTX has higher revenues than SMMT: BNTX (2.69B) vs SMMT (0).
BNTXSMMTBNTX / SMMT
Capitalization23.9B13.5B177%
EBITDA-315.6M-183.16M172%
Gain YTD-5.514601.533-1%
P/E Ratio161.7626.36614%
Revenue2.69B0-
Total Cash17.3B487M3,552%
Total Debt255M32.5M785%
FUNDAMENTALS RATINGS
SMMT: Fundamental Ratings
SMMT
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
26
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
11
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BNTXSMMT
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
86%
Momentum
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
84%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 10 days ago
79%
Bullish Trend 7 days ago
87%
Declines
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
78%
Aroon
ODDS (%)
Bearish Trend 3 days ago
78%
N/A
View a ticker or compare two or three
Ad is loading...
BNTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SMMT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MPW4.310.03
+0.70%
Medical Properties Trust
HOUS3.970.02
+0.51%
Anywhere Real Estate
MGOL2.420.01
+0.41%
MGO Global Inc.
TELA2.92-0.12
-3.95%
TELA Bio
BRKR51.30-3.19
-5.85%
Bruker Corp

BNTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BNTX has been loosely correlated with MRNA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if BNTX jumps, then MRNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNTX
1D Price
Change %
BNTX100%
-3.71%
MRNA - BNTX
47%
Loosely correlated
-7.34%
AXON - BNTX
43%
Loosely correlated
-0.86%
TIL - BNTX
43%
Loosely correlated
-9.99%
CVAC - BNTX
34%
Loosely correlated
-4.87%
CRSP - BNTX
34%
Loosely correlated
+0.85%
More

SMMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SMMT has been closely correlated with BCDA. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if SMMT jumps, then BCDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMMT
1D Price
Change %
SMMT100%
-5.86%
BCDA - SMMT
70%
Closely correlated
-8.19%
VBIZF - SMMT
42%
Loosely correlated
N/A
DAWN - SMMT
32%
Poorly correlated
-7.05%
ERNA - SMMT
31%
Poorly correlated
-12.04%
BNTX - SMMT
31%
Poorly correlated
-3.71%
More